A Phase 3 Study of NTLA-2001 in ATTRv-PN | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
A Phase 3 Study of NTLA-2001 in ATTRv-PN	Amyloid Neuropathies, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, amyloidosis, familial amyloid neuropathy, hereditary amyloidosis, hereditary disease, inborn errors of metabolism, inherited neurodegenerative disorder, metabolic disease, nervous system disorder, neurodegenerative disease, neuromuscular disease, peripheral nervous system disorder, polyneuropathy, proteostasis deficiencies	Recruiting	Phase 3	2026-04-16		NCT06672237

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Intellia Therapeutics	7
Regeneron Pharmaceuticals	238

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Chang Gung Medical Foundation - Linkou Branch	Taoyuan	Taiwan	1
HCFMRP - Hospital das Clinicas da Faculdade de Medicina de Ribeirao Preto	Ribeirão Preto	Brazil	2
Hospital Británico de Buenos Aires	Buenos Aires	Argentina	3
Hospital das Clinicas da Universidade Estadual de Campinas (UNICAMP)	Campinas	Brazil	1
Hospital El Cruce	San Juan Bautista	Argentina	2
Hospital Italiano de Buenos Aires (HIBA)	Buenos Aires	Argentina	2
Instituto de Educacao, Pesquisa e Gestao em Saude	Rio de Janeiro	Brazil	1
National Institute of Medical Sciences and Nutrition - Salvador Zubiran (INCMNSZ)	Tlalpan	Mexico	1
National Taiwan University Hospital	Taipei	Taiwan	203
National University Hospital	Singapore	Singapore	46
PSEG Centro de Pesquisa Clinica S.A.	São Paulo	Brazil	2
Singapore General Hospital	Singapore	Singapore	33
Siriraj Hospital	Bangkok	Thailand	10
Taipei Veterans General Hospital	Taipei	Taiwan	64